Delivered-To: pgepnewsletter@gmail.com
Received: by 2002:a98:c004:0:b0:1eb:e128:bbe3 with SMTP id l4csp4026277eic;
        Mon, 15 Jan 2024 17:24:22 -0800 (PST)
X-Google-Smtp-Source: AGHT+IEzIQmPuijMVQgotm8CpA4dXzPxaLZ3FFweIU+MRpqgYAfWV7dtzMpnJ34KJBBgMzZp3VCe
X-Received: by 2002:ae9:e40f:0:b0:783:18f6:156a with SMTP id q15-20020ae9e40f000000b0078318f6156amr6070431qkc.125.1705368258433;
        Mon, 15 Jan 2024 17:24:18 -0800 (PST)
ARC-Seal: i=1; a=rsa-sha256; t=1705368258; cv=none;
        d=google.com; s=arc-20160816;
        b=B6XwU2LLPC70HaxVPtNCTkkfwTGQIpto/5EL7brwqMWOP1Fw5zNLBGkW6K47k3cBch
         MC9ZCHfgAsfFGAYNQcVco/pGOS3vVJ87Zm/xsES+Fkv5vGXPHEwGMT1zkXkFZGg4kWs2
         IhK+omfNmoD/Mzz2O6jYKpNg+a0msFUub8sdlGjDNibFAW5tlQAK9Q7DBeqBSvRRJP3+
         jrPxFDstb7/6m5Twm3XB4d3boHuaGMpc+5iWzVaQSPzGSmuvluEnT0qnVgtJRVkI6HHY
         xwrKPg3NBPq5SGCm/qQjVoQLcIxqe2zrhjhQUq/b3eM+LV3wkhfCaURS/8RzcPYTyGgx
         rdLA==
ARC-Message-Signature: i=1; a=rsa-sha256; c=relaxed/relaxed; d=google.com; s=arc-20160816;
        h=list-unsubscribe:to:reply-to:subject:message-id:mime-version:from
         :date:dkim-signature:dkim-signature;
        bh=+XdT7/CF1kBadO7K4uhcl+6h2A00+eu4JP2L1jaLds4=;
        fh=m8+yFGL9AGrkSifADXzxzWHypeMVd9MF7/kbikeN2H4=;
        b=DnBuoyZ5tmw9ahauk/eaN6hSInsXv0C3V4hNn2NEa5jbHuLyiGY2PQg/hzDfX8tPAU
         UmQ9EZ8mK75Fw3ZLNKWEAChme6u8e4/dGsg5U6WGLANnDIzX61HOg7qBczEtEIidwc3n
         GIY062OnvzYgetsW/OA9eYAJwg9xw8dErHiQPxNxUINaIJ9airI0bXrNducRfyYYL+C9
         O0kER9N51pp+DYlBr6SYjW9VIjDELXGOc/nGI7IZBqrdHxORkgAU5ExISu1nLJ9XoC3Q
         zLE5fK6H9Cxj6xnf92bFpfephp4OKXDUxviwFOyzTkForflpAhMuvXzMoqN3FcvjFzEG
         qREQ==
ARC-Authentication-Results: i=1; mx.google.com;
       dkim=pass header.i=@isid.org header.s=s1 header.b=dnYknGuy;
       dkim=pass header.i=@sendgrid.info header.s=smtpapi header.b=Nx8cOEbS;
       spf=pass (google.com: domain of bounces+19268662-547c-pgepnewsletter=gmail.com@em7004.isid.org designates 167.89.81.226 as permitted sender) smtp.mailfrom="bounces+19268662-547c-pgepnewsletter=gmail.com@em7004.isid.org";
       dmarc=pass (p=NONE sp=NONE dis=NONE) header.from=isid.org
Return-Path: <bounces+19268662-547c-pgepnewsletter=gmail.com@em7004.isid.org>
Received: from xtrwrkzn.outbound-mail.sendgrid.net (xtrwrkzn.outbound-mail.sendgrid.net. [167.89.81.226])
        by mx.google.com with ESMTPS id de32-20020a05620a372000b0078341846c86si9592494qkb.414.2024.01.15.17.24.18
        for <pgepnewsletter@gmail.com>
        (version=TLS1_3 cipher=TLS_AES_128_GCM_SHA256 bits=128/128);
        Mon, 15 Jan 2024 17:24:18 -0800 (PST)
Received-SPF: pass (google.com: domain of bounces+19268662-547c-pgepnewsletter=gmail.com@em7004.isid.org designates 167.89.81.226 as permitted sender) client-ip=167.89.81.226;
Authentication-Results: mx.google.com;
       dkim=pass header.i=@isid.org header.s=s1 header.b=dnYknGuy;
       dkim=pass header.i=@sendgrid.info header.s=smtpapi header.b=Nx8cOEbS;
       spf=pass (google.com: domain of bounces+19268662-547c-pgepnewsletter=gmail.com@em7004.isid.org designates 167.89.81.226 as permitted sender) smtp.mailfrom="bounces+19268662-547c-pgepnewsletter=gmail.com@em7004.isid.org";
       dmarc=pass (p=NONE sp=NONE dis=NONE) header.from=isid.org
DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=isid.org;
	h=content-type:from:mime-version:subject:reply-to:x-feedback-id:to:
	list-unsubscribe:cc:content-type:from:subject:to;
	s=s1; bh=+XdT7/CF1kBadO7K4uhcl+6h2A00+eu4JP2L1jaLds4=;
	b=dnYknGuykpELyJiGJpGtR7zu4tAo7XWbKLb8RU03VZZw3c6QdaJ7RVcX+qTDG0r5TCLJ
	bz98DqsbPyv6jpcQU8f7Ixd8BpaP6aJW3UsP8gkRXrMnNqxrgO06LWbYP9V93IYBKzp+3I
	WpMU6h9O2x8YhNlEq5feQ2CVe0FK9j58BHTM6eLiMhZdwQd/fyajQtWRCmKZ7KbyxyiQZF
	Q+qi45nSHWUAJmvrgbwIkaSz156KKD6MlBAaWnvl2nUtpSOf2YLRl70aUQscqnxnyL9GNg
	0TBW44vK5s3XzsZwF34EyfsG4WgtcoixmZO2+5kQf9+HSQV/m6FzDLcl2c5PWvrw==
DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=sendgrid.info;
	h=content-type:from:mime-version:subject:reply-to:x-feedback-id:to:
	list-unsubscribe:cc:content-type:from:subject:to;
	s=smtpapi; bh=+XdT7/CF1kBadO7K4uhcl+6h2A00+eu4JP2L1jaLds4=;
	b=Nx8cOEbSwFbplK2F1O1PczIkl25oWKgG56KchaqBfKGMiCEFNSMkSvcX33YXP72YRaU/
	S9840oBl5U71+rOARimMksttpewBJVQ9Ov+LEFOrA38oLIIKoamYHIlZ/bgxEILvP33jD2
	6kB/79dKgxD3cAVBdcs5e1kna00Yq+aA8=
Received: by filterdrecv-568669ddb-swlpm with SMTP id filterdrecv-568669ddb-swlpm-1-65A5DABE-8
        2024-01-16 01:24:14.267054999 +0000 UTC m=+7800174.655692448
Received: from MTkyNjg2NjI (unknown)
	by geopod-ismtpd-2 (SG) with HTTP
	id QMRaIKnSTFSx5UEi2e72Qg
	Tue, 16 Jan 2024 01:24:14.227 +0000 (UTC)
Content-Type: multipart/alternative; boundary=718bdfb0fe7fda6ec3695c947a8722b29abfeebdc03806fc9f43ff82b463
Date: Tue, 16 Jan 2024 01:24:17 +0000 (UTC)
From: ProMED <promed@isid.org>
Mime-Version: 1.0
Message-ID: <QMRaIKnSTFSx5UEi2e72Qg@geopod-ismtpd-2>
Subject: PRO/EDR> Measles - Portugal: (LI) imported
Reply-To: noreply@isid.org
X-Feedback-ID: 19268662:SG
X-SG-EID: 
 =?us-ascii?Q?lYKUi1ucKQwcfoVB1xAcbBSlsJP9QSi7ed2VWI0p5NjpCc5BQK+kujBGGO1mU1?=
 =?us-ascii?Q?iBESxbQ5xzmRTVMAiKNvSA7O0hlZ2zfGiZwPvp9?=
 =?us-ascii?Q?QS5KCJwL0VgpM4BTEmGlUksl3jIxYA19t98=2F6YN?=
 =?us-ascii?Q?evAareIXsgVtFFbljhqEt6WXKifVHGeEoHd=2FN83?=
 =?us-ascii?Q?Pl=2FVj4zXpCWIM20hh3fyDWcpkxVPBh6prqWI6C9?=
 =?us-ascii?Q?63mQ7eMyrao54tmjpGwHNxM8eWm3OaayLyC5y+?=
X-SG-ID: 
 =?us-ascii?Q?se=2F49CGmbS0sfR97ImeXvNhg9p9jggtUUChgqoY2wUhc93xcG=2F095a5S4+mt=2FG?=
 =?us-ascii?Q?uYUpctI=2FOGD2dwyi+uvm2j4FCdvuw0l9zcHM8iA?=
 =?us-ascii?Q?mojOvTXq7jOpDFFNtfsYkHQYACEW8pq1BXXqYmH?=
 =?us-ascii?Q?oGTsnt6QpE2ZV5WVqnpwfXWoLXx7+4Ye2AVEAFp?=
 =?us-ascii?Q?IGvSb2IijBNhwpIGLGywVclum0gB4pvXJVBVP1O?=
 =?us-ascii?Q?EPsN=2FRmkXJEHLQ3tAyTtfNbqGS9mrQcvu0m7RBE?=
 =?us-ascii?Q?e4h5fdIpYnUsyuBasE5iystT+e3gXuYS+iyUm98?=
 =?us-ascii?Q?pT7aUjXM3tBdj64cMXsZaspbQuTLZtmXkw1znT=2F?=
 =?us-ascii?Q?b6VO+5JWd1pXC4r=2FQdWaAUWnxFTl1S3loOKe8Dn?=
 =?us-ascii?Q?iec0KyHFqbOVtWYpqEpE72OVEpGK9tIilMHErmu?=
 =?us-ascii?Q?ZFNw8eBUNHrMdwxS1OXh522hOLlGqAtSU7uCppp?=
 =?us-ascii?Q?W5ureKP7bu9jVWnziSU3D5NCXXPzzMxiWt9Jy8z?=
 =?us-ascii?Q?5=2FX0fJIndnE=2FNlnHw1fBJ9Gvis8F3DL3RaIzgXC?=
 =?us-ascii?Q?zxOilP2RoMx5w5eiH=2F44IxaJk8j0oV244EqMgZc?=
 =?us-ascii?Q?YkrpLMqgJ5FrL7QK2m1oxBFhiUH7HD8JZn8tZJf?=
 =?us-ascii?Q?voLdjKtZ61=2F3sKEPjvpVgSu8zF1Z1U+Z=2FeCuR7W?=
 =?us-ascii?Q?zebDy7uRoX8nRfNZ8nBfhe8OJBBOw0FJZ0QVDYX?=
 =?us-ascii?Q?t=2FdqRoZ1N6mPYuKoVHl8VPlhRibqTA3xSUSGx4s?=
 =?us-ascii?Q?p9ui7gz=2F=2FeJXUjmHzHcbbCHtVlp+RdvFUO7rSXG?=
 =?us-ascii?Q?geX2WkSNQ+pW1CJVLJVG=2FxyENA=3D=3D?=
To: pgepnewsletter@gmail.com
X-Entity-ID: 3CKJgmVGbBVD214dsRqreg==
List-Unsubscribe: 
 =?us-ascii?Q?=3Cmailto=3Aunsubscribe=40em7004=2Eisid=2Eorg=3Fsubject=3D19268662=2EW=5FgHi2fIO?=
 =?us-ascii?Q?FoTm5W4DAyuxJcNHRR4Hq467dluom8sVGVoMDAw?=
 =?us-ascii?Q?dTAwMNqgC42nFepr6rTl8X4F8=5FReHVAV-92UN=5F0?=
 =?us-ascii?Q?MEq-Pm-2BM-EmihLes118pgxMH9Z1N-=5Fabv7gg=5F?=
 =?us-ascii?Q?AkRq5piO9ElsKs---nDKm-srP0mYRI-kFtrFgeI?=
 =?us-ascii?Q?WBPACx6-y=5F8JtVIHw=3D=3D=2E8UDgCV9T1uHax3R0Sv6?=
 =?us-ascii?Q?VaxNlhyvzlLWAEVRwnRlb-HdoMDAwdTAwMB6Dgv?=
 =?us-ascii?Q?VUmEKA131r5qd1xUNAncvV7=5FP4WtEBL4MUUA5aO?=
 =?us-ascii?Q?aTta3Hl2TKz=5FSDMDBMgkCLcLBvck3uWgA3rZeUZ?=
 =?us-ascii?Q?wnjsPomQCQqK9Hmcc5v=5FEbkZf7SfVB5iVY07h5w?=
 =?us-ascii?Q?8D--hhsyNX3rC2T4Ds4vHNuJ7zs79mHpbB6=5FBX7?=
 =?us-ascii?Q?SC4ByerY8xUnpLlkpjBki02-MueXiiC20dOBDFG?=
 =?us-ascii?Q?o-4JS7FOMtDMKSs-51Gr0fGqynFvVkTq3cA3PNo?=
 =?us-ascii?Q?qkKSyZ1MdM-aUnCqph-BPLuIGl90f5FZqPF7aYz?=
 =?us-ascii?Q?PppLnuPpss2mgbKkFKna1A6YiF=5F2vHqGjJJHCJi?=
 =?us-ascii?Q?vmPl4aGB0Pz4FgKJEfyQKHkQvFgssr-pR83u3oM?=
 =?us-ascii?Q?QVfvgUkbnrFZdDNFvNMgrLpPyg=5F5K1e1VjCuCt4?=
 =?us-ascii?Q?qZHizHuU6p8Gy78Cz72Zn4wlqk06UsN5J51hVmb?=
 =?us-ascii?Q?YjH3eMEMQTcyXXbpFCCQCpflTr=5FnHYAewRZLpcl?=
 =?us-ascii?Q?sK842o7-gvYJ7exLvSIZVyxcUz8rW1Ohb7XtYEp?=
 =?us-ascii?Q?gYaTbWoXoVcJxYbo5Pn6d7AcodB=5Fr5c0VXMw8rH?=
 =?us-ascii?Q?euWLWlVXPFu7R8kyZjLCgwPnTK-qMKTqgCnW3hl?=
 =?us-ascii?Q?E5BacV434OwdJHc34wa7sjmqrLlZxMoyX=5FxOri6?=
 =?us-ascii?Q?Vz-SF69CNOvly7yAhlrQOl02ZROM3YqtICywpsK?=
 =?us-ascii?Q?5k7cS2gsR9gvBF4Il3FAUwClWeDKHXnRDdXvTh2?=
 =?us-ascii?Q?-SwmFIoCnaVXIed6KUl6o7aYXIthhmPVEi3mY5c?=
 =?us-ascii?Q?gvPiDyfmDEBZgAMz8UfZn-r7NdH7Nr9ssvj9Noa?=
 =?us-ascii?Q?42CYPWsL3O4O5Qb5K1o-medUu-wzz7U9PlV5b6t?=
 =?us-ascii?Q?iLmRz=5Fo41bwQxbNyw9-g-18WQHncgGn8Ko4XSJk?=
 =?us-ascii?Q?bf=5FoOO9QRXYZrKCxhBlbQG3jyWLUqiyk=5FGJ5XnD?=
 =?us-ascii?Q?yJ-IPtf83-VK=5FEW3MBOs702aM38tL2XvCdPKrAO?=
 =?us-ascii?Q?=5F0Jk=5FPaMWTPN6TmHXq3YMNNpZzQ1oqRaerjhAAy?=
 =?us-ascii?Q?r1afNtRO-4DUPgV9QS-xQq5=3E?=

--718bdfb0fe7fda6ec3695c947a8722b29abfeebdc03806fc9f43ff82b463
Content-Transfer-Encoding: quoted-printable
Content-Type: text/plain; charset=iso-8859-1
Mime-Version: 1.0

MEASLES - PORTUGAL: (LISBON) IMPORTED
*************************************
A ProMED-mail post
<http://www.promedmail.org>
ProMED-mail is a program of the
International Society for Infectious Diseases
<http://www.isid.org>

Date: Sat 13 Jan 2024
Source: CNN [in Portuguese, machine trans., edited]
<https://cnnportugal.iol.pt/sarampo/dgs/um-caso-de-sarampo-na-regiao-de-lis=
boa-dgs-reitera-apelo-para-vacinacao/20240113/65a2e86dd34e371fc0bbed2f>


A case of measles in the Lisbon region, DGS reiterates call for
vaccination
---------------------------------------------------------------------------
The diagnosis of an imported case of measles in the Lisbon and Tagus
Valley region led the Directorate-General for Health (DGS) to call
again this Saturday [13 Jan 2024] for vaccination, following the
increase in cases in Europe in 2023. In a statement, the DGS indicated
that the measles case was diagnosed in a 20-month-old child
non-resident of Portugal and not vaccinated, who is hospitalized and
"clinically stable, expected to be discharged in the next few days",
and that there are, so far, no records of spread.

"To date, no other associated cases of measles have been identified",
highlighted the DGS, adding that "a detailed investigation of the
situation is underway, which includes the collection of clinical,
laboratory and epidemiological information on the case, the
investigation of its origin, identification of close contacts in the
community and application of appropriate control measures".

After the notification of the case, on 10 Jan 2024, and its laboratory
confirmation by the National Institute of Health Dr Ricardo Jorge
(INSA), "the DGS and the network of Health Authorities, in
collaboration with INSA and the health professionals, are monitoring
the evolution of the situation in accordance with the provisions of
the National Measles Elimination Program", reads the statement.

Following what the WHO did in the face of an alarming increase in the
number of measles cases in Europe in 2023, the DGS reiterated its call
for vaccination, recalling that "measles is one of the most contagious
infectious diseases, which can cause serious illness in unvaccinated
people."

"This case of imported measles reinforces the importance of
maintaining high population vaccination coverage, which is why the DGS
reinforces the call for the importance of vaccination, in accordance
with the National Vaccination Program", which provides 2 doses for
children and adults born after 1970.

--
Communicated by:=20
ProMED
from
ProMED-PORT

[Measles is an acute viral respiratory illness. It is characterized by
a prodrome of fever (as high as 105=B0F; 45.56=B0C) and malaise, cough,
coryza, and conjunctivitis -- the three "C"s -- a pathognomonic
enanthem (Koplik spots) followed by a maculopapular rash. The rash
usually appears about 14 days after a person is exposed. The rash
spreads from the head to the trunk to the lower extremities. Patients
are considered to be contagious from 4 days before to 4 days after the
rash appears. The infection is preventable using 2 doses of a live,
attenuated virus usually combined with mumps and rubella vaccines.

Koplik spots
(<https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2645467/#:~:text=3DKoplik%20=
spots%20are%20highly%20characteristic,a%20pathognomonic%20feature%20of%20me=
asles>)
are highly characteristic of the prodromal phase of measles and can
often be identified before the onset of the rash. Since they were
originally described in 1896, these millimetric, erythematous, white
or grey specks on the buccal mucosa have been regarded as a
pathognomonic feature of measles. They typically appear opposite to
the upper molars a couple of days before the rash, occasionally extend
to the whole buccal mucosa, then disappear as the rash develops.
Koplik spots can be noted in at least 50%-70% of patients with measles
if examination is timely. Occasionally, they also occur on the
conjunctiva, the vaginal mucosa or the gastrointestinal mucosa. The
spots can be seen at the cited URL.

The classical rash of measles (or rubeola) begins on the head and
descends downwards to the feet. Generally, it takes about 3 days to
reach the feet and remains for about 3 days once starting in an area
so the rash lasts for about a week. The rash can be seen at
<https://www.cdc.gov/measles/symptoms/photos.html>.

The incubation period of measles averages about 14 days. So, in this
case, secondary cases may still occur in unimmunized individuals. -
Mod.LL

ProMED map:
Portugal: <https://promedmail.org/promed-post?place=3D8714250,42>]

[See Also:
Measles - Israel: (north) nosocomial
http://promedmail.org/post/20240113.8714196
Measles update (01): USA (PA) multiple potential exposure sites
http://promedmail.org/post/20240107.8714111
2023
----
Measles update (64): USA, Russia, Azerbaijan
http://promedmail.org/post/20231226.8713899
Measles update (31): Americas, Asia, Africa
http://promedmail.org/post/20230707.8711001
Measles update (30): W Pacific, Americas, E Mediterranean, Africa,
int'l travel http://promedmail.org/post/20230704.8710940
Measles update (29): E Mediterranean, Europe, Africa, Americas, int'l
travel http://promedmail.org/post/20230624.8710728
Measles update (28): Americas, E Mediterranean, W Pacific
http://promedmail.org/post/20230619.8710660
Measles update (21): global update
http://promedmail.org/post/20230428.8709755
Measles update (20): Europe, Asia, Africa, W. Pacific, Americas,
Middle East http://promedmail.org/post/20230423.8709653]
.................................................rna/ll/may/jh
*##########################################################*
************************************************************
ProMED makes every effort to verify the reports that are posted, but the ac=
curacy
and completeness of the information, and of any statements or opinions base=
d
thereon, are not guaranteed. The reader assumes all risks in using informat=
ion
posted or archived by ProMED. ISID and its associated service providers sha=
ll not
be held responsible for errors or omissions or held liable for any damages =
incurred
as a result of use or reliance upon posted or archived material.
************************************************************
Donate to ProMED. Details available at: https://isid.networkforgood.com/pro=
jects/79924-invest-in-the-mission.
************************************************************
Visit ProMED's website at https://www.promedmail.org/.
Submit all items for posting via the ProMED website at https://promedmail.o=
rg/submitinfo/.
If you have any questions or need support, please contact us via the ProMED=
 website at  https://promedmail.org/support/.
You may subscribe/unsubscribe at  https://isid.org/promedmail-subscribe/.
Unsubscribe Preferences ( https://u19268662.ct.sendgrid.net/asm/?user_id=3D=
19268662&data=3DYxDx-jOwEXPXqCraxZSod1euAQSvFj8ZafT8lCLlIopoMDAwdTAwMCXaHp4=
uOptztd-IaHnICMZMtV-i96NIwL2N5wA3pKJ0RqPTXy8nknCmdl3hgtwWHvhc1mLhbR8NrfgUAX=
PhHJ4fJOTeTjVvYhmpHCGPan-RBP3dSFePSekNJzQgltsQYerDGQ45G77UiC7Ud8fvrGwoRkUCW=
5QoBDUW2_xNXNNXyYc3Vh-oq8VJrAyP0lo-8ehAD3UHhQEgRUOITXARpgHRiQqHGUmthRma3Sjv=
KrWAzTv6p8qVcFqFQkyJDJZVp7l-TbSCnvVuM7QHje7uOBacgDkTzSXhb0ILWaAJTnV8QWxzQMX=
GGbNvg5JETHQiSVPozehbPI9BIqHG5cPN9HfH_3pfOpbh-cfsySyRv2XrPojuZP5pP6KZiZSsJo=
qyegresxqdv9C0S436RuZi_EC1aJGisJ5J3KRazWzBvieG6IkbtxdgAxr9Zq6kitC76CzhBwA8C=
syLYpF__RyNUFoV8mjB_w4pV2mgMs_xnCjTXToJ45Wf8YuuOGS91bj_f-uzqo4XW14I1l3503zJ=
kR3O_ImvH0QihXQWsCsOIasBPjb8etREci7nO2PDTpGk0-48DQUcXhQHKiCyb08UalvXz_12tEy=
D9nc0sDpCu8JBImV8mZY1WtJ7_CMZNqhDpp46_lRGChgyxQz-yQ4xN-TWfI7WysuXKo4QrVo8Gm=
p8GH_wydvTNYfBhGuV6v_QIHpsqLepyHhhPXHIS1Cq1K71pd-RhxI7KCO3jaW_njNW6SgeHRfHQ=
i3vID1GXR7ok5jSrWNcBTbQhB8vzp16pPbscfO8UsrqBV-AjzTgtq9sOiIAeMzHnFsGVb9TFPzZ=
u3YLq4rLINtWAIBGIuk73b_n3defsKHR6EvZ5xrDDhUNKCDcPRHzX1eGg3QwW3TBq_GquqqlB0h=
1nLpazd8lSob_cXsVU5uyN1DXl_zD9p9n96cvuYjBEBuWDV3MHOLS7iGIJ7ygQ_6J4W-n0BvHNY=
GX-mnyItTZVCPUBA6VL-cF5K2YnUSj_tb7WzIFcT55f1I-I0IQisBxRqvMlSQ9ZAAlBmhDegkoK=
WpIl7xL_Ij5ezHgtQNCovDRN3Gd_ujJ-da7mU_xzj9ntvPOm-dQ6iY4qCsVANbivRYDteTJWAzi=
4fkZfsII9UVW0yjRqK3KTxFbWXrBC5-_vCCnlKTXJ_g=3D )
############################################################
############################################################

--718bdfb0fe7fda6ec3695c947a8722b29abfeebdc03806fc9f43ff82b463
Content-Transfer-Encoding: quoted-printable
Content-Type: text/html; charset=iso-8859-1
Mime-Version: 1.0

<!DOCTYPE HTML>
<html>
<head>
<meta http-equiv=3D"Content-Type" content=3D"text/html; charset=3DUTF-8" />
</head>
<body>MEASLES - PORTUGAL: (LISBON) IMPORTED<br>****************************=
*********<br>A ProMED-mail post<br><a href=3D"https://u19268662.ct.sendgrid=
.net/ss/c/wscE2ng5fl6JrPIt48tisIijpefK5PNjW-mL-YZGnfgDOxU1G3gjwnPSi2Tfv3HA/=
431/OGpUkEJKSRKC0sBWErWeHg/h0/MfKUm5Pg85j_9muyREmHSp8Y5D_dyIwLWf7Flu2Zw9Y">=
http://www.promedmail.org</a><br>ProMED-mail is a program of the<br>Interna=
tional Society for Infectious Diseases<br><a href=3D"https://u19268662.ct.s=
endgrid.net/ss/c/wscE2ng5fl6JrPIt48tisCT5tpD4Upm3qyMCbcYSQvc/431/OGpUkEJKSR=
KC0sBWErWeHg/h1/58oreNsW039ZRSGhvWCAl3ywncuYCcTDYqEE0QJ-134">http://www.isi=
d.org</a><br><br>Date: Sat 13 Jan 2024=0D<br>Source: CNN [in Portuguese, ma=
chine trans., edited]=0D<br><a href=3D"https://u19268662.ct.sendgrid.net/ss=
/c/jf2l8IGiVWEHUuN2KNp3mWa0hXX6D9tGoC_UA3muNNlp8DOvWzMlttKY7Bzbh9idF-uhfnv1=
FyWOGg0FVIh5tzjixIuDgeaUYuYb1zZqTSR9V82PS9q_R-QqFDXlyY8BN0GlWL7vx9yLviQDDCE=
FJJ-v2kNgiwM3zplyr6OC_5zO4LlNyJhz5HLeTk0X1K5VaApUhh41wXGq54xj_88lkw/431/OGp=
UkEJKSRKC0sBWErWeHg/h2/KUlfnRa19jgQIgK7j4RQv3nZzxTLYr_hpG9icf_W8i4">https:/=
/cnnportugal.iol.pt/sarampo/dgs/um-caso-de-sarampo-na-regiao-de-lisboa-dgs-=
reitera-apelo-para-vacinacao/20240113/65a2e86dd34e371fc0bbed2f</a>=0D<br>=0D=
<br>=0D<br>A case of measles in the Lisbon region, DGS reiterates call for<=
br>vaccination=0D<br>------------------------------------------------------=
---------------------=0D<br>The diagnosis of an imported case of measles in=
 the Lisbon and Tagus<br>Valley region led the Directorate-General for Heal=
th (DGS) to call<br>again this Saturday [13 Jan 2024] for vaccination, foll=
owing the<br>increase in cases in Europe in 2023. In a statement, the DGS i=
ndicated<br>that the measles case was diagnosed in a 20-month-old child<br>=
non-resident of Portugal and not vaccinated, who is hospitalized and<br>"cl=
inically stable, expected to be discharged in the next few days",<br>and th=
at there are, so far, no records of spread.=0D<br>=0D<br>"To date, no other=
 associated cases of measles have been identified",<br>highlighted the DGS,=
 adding that "a detailed investigation of the<br>situation is underway, whi=
ch includes the collection of clinical,<br>laboratory and epidemiological i=
nformation on the case, the<br>investigation of its origin, identification =
of close contacts in the<br>community and application of appropriate contro=
l measures".=0D<br>=0D<br>After the notification of the case, on 10 Jan 202=
4, and its laboratory<br>confirmation by the National Institute of Health D=
r Ricardo Jorge<br>(INSA), "the DGS and the network of Health Authorities, =
in<br>collaboration with INSA and the health professionals, are monitoring<=
br>the evolution of the situation in accordance with the provisions of<br>t=
he National Measles Elimination Program", reads the statement.=0D<br>=0D<br=
>Following what the WHO did in the face of an alarming increase in the<br>n=
umber of measles cases in Europe in 2023, the DGS reiterated its call<br>fo=
r vaccination, recalling that "measles is one of the most contagious<br>inf=
ectious diseases, which can cause serious illness in unvaccinated<br>people=
."=0D<br>=0D<br>"This case of imported measles reinforces the importance of=
<br>maintaining high population vaccination coverage, which is why the DGS<=
br>reinforces the call for the importance of vaccination, in accordance<br>=
with the National Vaccination Program", which provides 2 doses for<br>child=
ren and adults born after 1970.=0D<br>=0D<br>--=0D<br>Communicated by:=20=0D=
<br>ProMED=0D<br>from=0D<br>ProMED-PORT<br><br>[Measles is an acute viral r=
espiratory illness. It is characterized by<br>a prodrome of fever (as high =
as 105=B0F; 45.56=B0C) and malaise, cough,<br>coryza, and conjunctivitis --=
 the three "C"s -- a pathognomonic<br>enanthem (Koplik spots) followed by a=
 maculopapular rash. The rash<br>usually appears about 14 days after a pers=
on is exposed. The rash<br>spreads from the head to the trunk to the lower =
extremities. Patients<br>are considered to be contagious from 4 days before=
 to 4 days after the<br>rash appears. The infection is preventable using 2 =
doses of a live,<br>attenuated virus usually combined with mumps and rubell=
a vaccines.=0D<br>=0D<br>Koplik spots<br>(<a href=3D"https://u19268662.ct.s=
endgrid.net/ss/c/sSnCkKCWBvais3EuVAOvgx-X_Tayiv97ISHEOXfw95mvokWBt9LdMe7KHL=
T5QWUfGfZdqiv8u-yZe5ZPVaQAAEOR7FTV4of1bZHDiYmukB6u8FjancFZDc0c3VV-oJ4hHW9LG=
RGcT6Yu8WkLHcuJ1gHsPRSBq1-sDJcEVW1f-FuZo8VY5Qn5u3TY-KBXtVbmXJP6hlwpvt1MGEKj=
ZLtHRpiAutZxhFcDAPSzTgxOYZE/431/OGpUkEJKSRKC0sBWErWeHg/h3/U_689Wd_rtnoGu2of=
a4IK9KrJc26NDsEhtk9ER90ty0">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC26=
45467/#:~:text=3DKoplik%20spots%20are%20highly%20characteristic,a%20pathogn=
omonic%20feature%20of%20measles</a>)<br>are highly characteristic of the pr=
odromal phase of measles and can<br>often be identified before the onset of=
 the rash. Since they were<br>originally described in 1896, these millimetr=
ic, erythematous, white<br>or grey specks on the buccal mucosa have been re=
garded as a<br>pathognomonic feature of measles. They typically appear oppo=
site to<br>the upper molars a couple of days before the rash, occasionally =
extend<br>to the whole buccal mucosa, then disappear as the rash develops.<=
br>Koplik spots can be noted in at least 50%-70% of patients with measles<b=
r>if examination is timely. Occasionally, they also occur on the<br>conjunc=
tiva, the vaginal mucosa or the gastrointestinal mucosa. The<br>spots can b=
e seen at the cited URL.=0D<br>=0D<br>The classical rash of measles (or rub=
eola) begins on the head and<br>descends downwards to the feet. Generally, =
it takes about 3 days to<br>reach the feet and remains for about 3 days onc=
e starting in an area<br>so the rash lasts for about a week. The rash can b=
e seen at<br><a href=3D"https://u19268662.ct.sendgrid.net/ss/c/TLh_csrC34X_=
iXpbYoMamyjNbSzOG8uHHjXQPwsjHwi1q4TpVWh6NSrqM8qlhayKiXgXyJrNT03LA04zqMVoAQ/=
431/OGpUkEJKSRKC0sBWErWeHg/h4/iHc7hO9ynKIDPjebbUPE6jdNvraHe89x5dbcczlMbx8">=
https://www.cdc.gov/measles/symptoms/photos.html</a>.=0D<br>=0D<br>The incu=
bation period of measles averages about 14 days. So, in this<br>case, secon=
dary cases may still occur in unimmunized individuals. -<br>Mod.LL<br><br>P=
roMED map:<br>Portugal: <a href=3D"https://u19268662.ct.sendgrid.net/ss/c/s=
SnCkKCWBvais3EuVAOvgy2WOIX7pp1nXnn4AbwuQ3Z6WbkfhqXYXU-aTMPJ8yThnxBPfic8QTZr=
R1UITsBPqg/431/OGpUkEJKSRKC0sBWErWeHg/h5/9Sln94LX77g_cWMSHAo2CMUpO13MFoKBYm=
0pe7g9O9U">https://promedmail.org/promed-post?place=3D8714250,42</a>]<br><b=
r>[See Also:<br>Measles - Israel: (north) nosocomial<br>http://promedmail.o=
rg/post/20240113.8714196=0D<br>Measles update (01): USA (PA) multiple poten=
tial exposure sites<br>http://promedmail.org/post/20240107.8714111=0D<br>20=
23=0D<br>----=0D<br>Measles update (64): USA, Russia, Azerbaijan<br>http://=
promedmail.org/post/20231226.8713899=0D<br>Measles update (31): Americas, A=
sia, Africa<br>http://promedmail.org/post/20230707.8711001=0D<br>Measles up=
date (30): W Pacific, Americas, E Mediterranean, Africa,<br>int'l travel ht=
tp://promedmail.org/post/20230704.8710940=0D<br>Measles update (29): E Medi=
terranean, Europe, Africa, Americas, int'l<br>travel http://promedmail.org/=
post/20230624.8710728=0D<br>Measles update (28): Americas, E Mediterranean,=
 W Pacific<br>http://promedmail.org/post/20230619.8710660=0D<br>Measles upd=
ate (21): global update<br>http://promedmail.org/post/20230428.8709755=0D<b=
r>Measles update (20): Europe, Asia, Africa, W. Pacific, Americas,<br>Middl=
e East http://promedmail.org/post/20230423.8709653]<br>....................=
.............................rna/ll/may/jh<br></body>
</html><!DOCTYPE HTML>
<html>
<head>
<meta http-equiv=3D"Content-Type" content=3D"text/html; charset=3DUTF-8" />
</head>
<body>*##########################################################*<br>*****=
*******************************************************<br>ProMED makes eve=
ry effort to verify the reports that are posted, but the accuracy<br>and co=
mpleteness of the information, and of any statements or opinions based<br>t=
hereon, are not guaranteed. The reader assumes all risks in using informati=
on<br>posted or archived by ProMED. ISID and its associated service provide=
rs shall not<br>be held responsible for errors or omissions or held liable =
for any damages incurred<br>as a result of use or reliance upon posted or a=
rchived material.<br>******************************************************=
******<br>Donate to ProMED. Details available at: https://isid.networkforgo=
od.com/projects/79924-invest-in-the-mission.<br>***************************=
*********************************<br>Visit ProMED's website at https://www.=
promedmail.org/.<br>Submit all items for posting via the ProMED website at =
https://promedmail.org/submitinfo/.<br>If you have any questions or need su=
pport, please contact us via the ProMED website at  https://promedmail.org/=
support/.<br>You may subscribe/unsubscribe at  https://isid.org/promedmail-=
subscribe/.<br><div><a href=3D"https://u19268662.ct.sendgrid.net/asm/?user_=
id=3D19268662&amp;data=3DYxDx-jOwEXPXqCraxZSod1euAQSvFj8ZafT8lCLlIopoMDAwdT=
AwMCXaHp4uOptztd-IaHnICMZMtV-i96NIwL2N5wA3pKJ0RqPTXy8nknCmdl3hgtwWHvhc1mLhb=
R8NrfgUAXPhHJ4fJOTeTjVvYhmpHCGPan-RBP3dSFePSekNJzQgltsQYerDGQ45G77UiC7Ud8fv=
rGwoRkUCW5QoBDUW2_xNXNNXyYc3Vh-oq8VJrAyP0lo-8ehAD3UHhQEgRUOITXARpgHRiQqHGUm=
thRma3SjvKrWAzTv6p8qVcFqFQkyJDJZVp7l-TbSCnvVuM7QHje7uOBacgDkTzSXhb0ILWaAJTn=
V8QWxzQMXGGbNvg5JETHQiSVPozehbPI9BIqHG5cPN9HfH_3pfOpbh-cfsySyRv2XrPojuZP5pP=
6KZiZSsJoqyegresxqdv9C0S436RuZi_EC1aJGisJ5J3KRazWzBvieG6IkbtxdgAxr9Zq6kitC7=
6CzhBwA8CsyLYpF__RyNUFoV8mjB_w4pV2mgMs_xnCjTXToJ45Wf8YuuOGS91bj_f-uzqo4XW14=
I1l3503zJkR3O_ImvH0QihXQWsCsOIasBPjb8etREci7nO2PDTpGk0-48DQUcXhQHKiCyb08Ual=
vXz_12tEyD9nc0sDpCu8JBImV8mZY1WtJ7_CMZNqhDpp46_lRGChgyxQz-yQ4xN-TWfI7WysuXK=
o4QrVo8Gmp8GH_wydvTNYfBhGuV6v_QIHpsqLepyHhhPXHIS1Cq1K71pd-RhxI7KCO3jaW_njNW=
6SgeHRfHQi3vID1GXR7ok5jSrWNcBTbQhB8vzp16pPbscfO8UsrqBV-AjzTgtq9sOiIAeMzHnFs=
GVb9TFPzZu3YLq4rLINtWAIBGIuk73b_n3defsKHR6EvZ5xrDDhUNKCDcPRHzX1eGg3QwW3TBq_=
GquqqlB0h1nLpazd8lSob_cXsVU5uyN1DXl_zD9p9n96cvuYjBEBuWDV3MHOLS7iGIJ7ygQ_6J4=
W-n0BvHNYGX-mnyItTZVCPUBA6VL-cF5K2YnUSj_tb7WzIFcT55f1I-I0IQisBxRqvMlSQ9ZAAl=
BmhDegkoKWpIl7xL_Ij5ezHgtQNCovDRN3Gd_ujJ-da7mU_xzj9ntvPOm-dQ6iY4qCsVANbivRY=
DteTJWAzi4fkZfsII9UVW0yjRqK3KTxFbWXrBC5-_vCCnlKTXJ_g=3D" target=3D"_blank" =
class=3D"Unsubscribe--unsubscribePreferences" style=3D"font-family:sans-ser=
if;text-decoration:none;">Unsubscribe Preferences</a></div><br>############=
################################################<br>#######################=
#####################################<br><br><img src=3D"https://u19268662.=
ct.sendgrid.net/ss/o/LbtalBvHhFtzyiegKfBhew/431/OGpUkEJKSRKC0sBWErWeHg/ho.g=
if" alt=3D"" width=3D"1" height=3D"1" border=3D"0" style=3D"height:1px !imp=
ortant;width:1px !important;border-width:0 !important;margin-top:0 !importa=
nt;margin-bottom:0 !important;margin-right:0 !important;margin-left:0 !impo=
rtant;padding-top:0 !important;padding-bottom:0 !important;padding-right:0 =
!important;padding-left:0 !important;"/></body>
</html>
--718bdfb0fe7fda6ec3695c947a8722b29abfeebdc03806fc9f43ff82b463--
